First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
J Melo-Cristino, C Resina, V Manuel, L Lito, M Ramirez - The Lancet, 2013 - thelancet.com
J Melo-Cristino, C Resina, V Manuel, L Lito, M Ramirez
The Lancet, 2013•thelancet.comAlthough vancomycin is often prescribed for the treatment of meticillin-resistant
Staphylococcus aureus (MRSA), vancomycin-resistant S aureus (VRSA) infections remain
rare, with only few cases confirmed worldwide—mostly in the USA. 1 Here, we report the
isolation and preliminary characterisation of the first VRSA strain in Europe isolated from a
patient in Portugal.
Staphylococcus aureus (MRSA), vancomycin-resistant S aureus (VRSA) infections remain
rare, with only few cases confirmed worldwide—mostly in the USA. 1 Here, we report the
isolation and preliminary characterisation of the first VRSA strain in Europe isolated from a
patient in Portugal.
Although vancomycin is often prescribed for the treatment of meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant S aureus (VRSA) infections remain rare, with only few cases confirmed worldwide—mostly in the USA. 1 Here, we report the isolation and preliminary characterisation of the first VRSA strain in Europe isolated from a patient in Portugal.
thelancet.com